We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Von Eschenbach Takes Charge

Analysis

Executive Summary

The appointment of interim FDA Commissioner Andrew von Eschenbach means that FDA is back to square one in a search for a permanent head of the agency. Von Eschenbach is on a short list of candidates to fill the position permanently. The real story of why Lester Crawford resigned as FDA chief so suddenly indicates Congress was not ready to go to bat for him.